A phase I trial of the bifunctional EGFR/TGFb fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors Meeting Abstract
| Authors: | Hanna, G. J.; Hernando Calvo, A.; Morris, V.; Carvajal, R. D.; Paik, P. K.; Zandberg, D. P.; Kaczmar, J.; Niculescu, L.; Reiners, R.; Bohr, D.; Gharakhani, E.; Salazar, R.; Bilic, S.; Bedard, P. L. |
| Abstract Title: | A phase I trial of the bifunctional EGFR/TGFb fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S877 |
| Language: | English |
| ACCESSION: | WOS:000866211601003 |
| DOI: | 10.1016/j.annonc.2022.07.857 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 731MO -- Source: Wos |
